Skip to main content
. Author manuscript; available in PMC: 2010 Feb 9.
Published in final edited form as: Gene Ther Mol Biol. 2008 Jan 1;12:395.

Figure 1.

Figure 1

Schematic representation of the current understanding of regulation of hormonal therapy resistance by cell cycle machinery. Convergence of growth factors and estrogen receptor signaling pathways in therapy resistant cells suggest that deregulation cell cycle regulators are likely to contribute to the development of therapy resistance in breast cancer cells.